Peel Hunt upgraded shares of Spire Healthcare Group (LON:SPI) to an add rating in a research report report published on Monday, Digital Look reports. Peel Hunt currently has GBX 155 ($2.03) price objective on the stock.

SPI has been the topic of a number of other reports. Liberum Capital reaffirmed a hold rating on shares of Spire Healthcare Group in a research note on Monday, August 5th. Royal Bank of Canada reaffirmed an outperform rating and issued a GBX 149 ($1.95) target price on shares of Spire Healthcare Group in a research note on Monday, September 9th. UBS Group started coverage on shares of Spire Healthcare Group in a research note on Tuesday, July 2nd. They issued a neutral rating and a GBX 120 ($1.57) target price on the stock. Finally, Barclays reissued an underweight rating and set a GBX 115 ($1.50) price target on shares of Spire Healthcare Group in a research note on Friday, August 9th. Two investment analysts have rated the stock with a sell rating, six have issued a hold rating and two have assigned a buy rating to the stock. Spire Healthcare Group currently has a consensus rating of Hold and an average target price of GBX 130.44 ($1.70).

Shares of SPI opened at GBX 112.70 ($1.47) on Monday. The firm’s 50 day simple moving average is GBX 106.29 and its 200 day simple moving average is GBX 121.30. The company has a market capitalization of $452.02 million and a P/E ratio of 40.25. The company has a debt-to-equity ratio of 48.52, a current ratio of 1.44 and a quick ratio of 0.95. Spire Healthcare Group has a 1-year low of GBX 95.25 ($1.24) and a 1-year high of GBX 176 ($2.30).

The firm also recently declared a dividend, which will be paid on Tuesday, December 10th. Shareholders of record on Thursday, November 14th will be paid a dividend of GBX 1.30 ($0.02) per share. This represents a dividend yield of 1.07%. The ex-dividend date is Thursday, November 14th. Spire Healthcare Group’s dividend payout ratio (DPR) is presently 1.43%.

About Spire Healthcare Group

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics in the United Kingdom. It provides a range of integrated surgical, medical, and diagnostic services. The company offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.

Featured Article: Stock Split

Analyst Recommendations for Spire Healthcare Group (LON:SPI)

Receive News & Ratings for Spire Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group and related companies with's FREE daily email newsletter.